Skip to main content

802 publications

Name Date Type Actions

In 2023 Vetoquinol celebrates its 90th anniversary.

The story of an incredible family saga. From a regional pharmaceutical laboratory to a world leader in animal health.

31/01/2023 Public releases

0 pages

Annual sales 2022

Total group Sales: €540 million (up 3.6% as reported)
Annual Sales of Essential products: €304 million (up 4.5% as reported)

18/01/2023 Public releases

0 pages

CALENDAR 2023 Stock exchange market – non authorized periods

The "negative windows" are the abstention periods during which it is forbidden to trade in the Company's securities.

13/01/2023 Financial Documents

0 pages

2023 calendar of financial communication

Vetoquinol published its calendar of financial communication for 2023.

10/01/2023 Agenda

0 pages

Monthly information regarding the total number of voting rights - december 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

05/01/2023 Voting rights

0 pages

Buyback programs - december 2022 Monthly communication regarding buyback programs

04/01/2023 Description of buyback programs

0 pages

Monthly information regarding the total number of voting rights ans shares making of the share capital - november

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

08/12/2022 Voting rights

0 pages

Buyback programs - november 2022

Monthly communication regarding buyback programs

08/12/2022 Description of buyback programs

0 pages

Monthly communication regarding buyback programs - october 2022

10/11/2022 Voting rights

0 pages

Buyback programs - october 2022

Monthly communication regarding buyback programs

10/11/2022 Description of buyback programs

0 pages